Body composition trials
Phase 2 obesity trials of AOD-9604 included female participants, with body weight and waist circumference as primary research endpoints.
Metabolic
AOD-9604
Adipose tissue research
A modified fragment of human growth hormone (residues 176–191) studied for lipolytic activity without classical GH effects.
$44.99per vial · research use
Quantity
Up to 50%
- Lipolysis models
- Body composition research
- Metabolic studies
For research use only. Not for human consumption.
Women's research notes
What researchers study AOD-9604 for in women
AOD-9604 has been studied in clinical trials that included female participants, focused on adiposity and body-composition endpoints relevant to mid-life metabolic shifts.
Adipose-specific research
Pre-clinical work shows lipolytic activity without classical GH-axis effects — relevant to research on sex-specific adipose distribution.
Cartilage research
Emerging pre-clinical research has explored chondrocyte effects, relevant to female-prevalent osteoarthritis research.
Selected literature
- Heffernan M, et al. JCEM 2001 — AOD9604 and lipolysis
- Ng FM, et al. Horm Res 2000 — Metabolic studies of hGH fragment
Information below summarizes published pre-clinical and clinical research. It is provided for educational purposes for qualified researchers and is not medical advice, a treatment recommendation, or a claim of efficacy. Products are sold for research use only.
